Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C063002 |
2,3-dimethoxy-1,4-naphthoquinone |
2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of SERPINC1 mRNA | decreases expression | 17547211
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of SERPINC1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of SERPINC1 mRNA | affects expression | 21346803
|
C041594 |
4-nonylphenol |
4-nonylphenol affects the expression of SERPINC1 mRNA | affects expression | 15792627
|
D000082 |
Acetaminophen |
Acetaminophen results in decreased expression of SERPINC1 protein | decreases expression | 16687475
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of SERPINC1 protein | affects expression | 20106945
|
D000965 |
Antimony |
Antimony results in decreased expression of SERPINC1 mRNA | decreases expression | 17547211
|
D000966 |
Antimony Potassium Tartrate |
Antimony Potassium Tartrate results in decreased expression of SERPINC1 mRNA | decreases expression | 17547211
|
D002104 |
Cadmium |
Cadmium results in decreased expression of SERPINC1 mRNA | decreases expression | 17547211
|
D019256 |
Cadmium Chloride |
Cadmium Chloride results in decreased expression of SERPINC1 mRNA | decreases expression | 17547211
|
D002857 |
Chromium |
Chromium results in decreased expression of SERPINC1 mRNA | decreases expression | 17547211
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of SERPINC1 mRNA | decreases expression | 20106945
|
C023635 |
dienogest |
[Ethinyl Estradiol co-treated with dienogest] results in decreased activity of SERPINC1 protein | affects cotreatment|decreases activity | 15288212
|
C418365 |
estradiol, norethindrone drug combination |
estradiol, norethindrone drug combination results in decreased expression of SERPINC1 protein | decreases expression | 14561536
|
C454300 |
estradiol valerate-dienogest |
[Ethinyl Estradiol co-treated with estradiol valerate-dienogest] results in decreased activity of SERPINC1 protein | affects cotreatment|decreases activity | 15288212
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol binds to Norethindrone] which results in decreased expression of SERPINC1 protein | affects binding|decreases expression | 14561536
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with dienogest] results in decreased activity of SERPINC1 protein | affects cotreatment|decreases activity | 15288212
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with estradiol valerate-dienogest] results in decreased activity of SERPINC1 protein | affects cotreatment|decreases activity | 15288212
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of SERPINC1 protein | affects cotreatment|decreases activity | 11994571
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] results in decreased expression of SERPINC1 protein | affects cotreatment|decreases expression | 12618251
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of SERPINC1 protein | affects cotreatment|decreases activity | 15288212
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of SERPINC1 protein | affects cotreatment|decreases expression | 14981370 12618251
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with norgestimate] results in decreased expression of SERPINC1 protein | affects cotreatment|decreases expression | 12618251
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased activity of SERPINC1 protein | decreases activity | 17374706
|
C442659 |
ethinyl estradiol-desogestrel combination |
ethinyl estradiol-desogestrel combination results in decreased activity of SERPINC1 protein | decreases activity | 11994571
|
C442659 |
ethinyl estradiol-desogestrel combination |
ethinyl estradiol-desogestrel combination results in decreased expression of SERPINC1 protein | decreases expression | 14981370 12618251 10928463
|
C442659 |
ethinyl estradiol-desogestrel combination |
ethinyl estradiol-desogestrel combination results in increased expression of SERPINC1 protein | increases expression | 15318540
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of SERPINC1 protein | affects cotreatment|decreases activity | 11994571
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] results in decreased expression of SERPINC1 protein | affects cotreatment|decreases expression | 12618251
|
D008628 |
Mercury |
Mercury results in decreased expression of SERPINC1 mRNA | decreases expression | 17547211
|
D008767 |
Methylmercury Compounds |
Methylmercury Compounds results in decreased expression of SERPINC1 mRNA | decreases expression | 16966085
|
C022838 |
nickel chloride |
nickel chloride results in decreased expression of SERPINC1 mRNA | decreases expression | 17547211
|
D009640 |
Norethindrone |
[Ethinyl Estradiol binds to Norethindrone] which results in decreased expression of SERPINC1 protein | affects binding|decreases expression | 14561536
|
C017576 |
norgestimate |
[Ethinyl Estradiol co-treated with norgestimate] results in decreased expression of SERPINC1 protein | affects cotreatment|decreases expression | 12618251
|
D016912 |
Levonorgestrel |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of SERPINC1 protein | affects cotreatment|decreases activity | 15288212
|
D016912 |
Levonorgestrel |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of SERPINC1 protein | affects cotreatment|decreases expression | 12618251 14981370
|
D011192 |
Potassium Dichromate |
Potassium Dichromate results in decreased expression of SERPINC1 mRNA | decreases expression | 17547211
|
C009277 |
sodium arsenate |
sodium arsenate results in decreased expression of SERPINC1 mRNA | decreases expression | 16882884
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of SERPINC1 mRNA | affects expression | 17450228
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
11.55 | 17505938 |
MESH:D000152 |
Acne Vulgaris |
|
norgestimate |
11.55 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.76 | 14692618 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.47 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.67 | 17306315 16712894 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.61 | 10982225 |
MESH:D020152 |
Antithrombin III Deficiency |
marker/mechanism |
|
| |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.24 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.53 | 15885639 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
3.51 | 15687053 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.14 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.14 | 17497416 |
MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
4.65 | 16634805 |
MESH:D001943 |
Breast Neoplasms |
|
Chromium |
3.52 | 15986119 |
MESH:D001991 |
Bronchitis |
|
Antimony |
5.90 | 8768112 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.45 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.45 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.45 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
8.45 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.45 | 15276417 16507464 17306315 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.32 | 18572023 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Antimony |
6.28 | 10334427 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
6.28 | 10334427 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.45 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
14.78 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
14.78 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
14.78 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
14.78 | 19524636 20056578 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.66 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
12.66 | 17333356 15861022 17110522 11677210 16919318 16105132 17681005 |
MESH:D002779 |
Cholestasis |
|
Levonorgestrel |
12.66 | 15861022 |
MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
2.71 | 10525206 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.14 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.14 | 18551238 |
MESH:D003704 |
Dementia |
|
Methylmercury Compounds |
4.79 | 16140633 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
7.00 | 16823706 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Potassium Dichromate |
7.00 | 16823706 |
MESH:D004283 |
Dog Diseases |
|
Antimony |
5.43 | 12019027 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
8.43 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
8.43 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.43 | 12153990 11287661 19420014 12705907 12594235 16393943 19416960 16485898 12540782 17906064 11739529 2444490 18713872 16177239 11743745 19923254 11461765 12958197 19164858 10915739 10663392 19085960 11529661 17522070 15619225 16109766 19739265 14725611 14550746 15968718 11421492 18071297 19370779 16081117 16227642 11834606 17562736 12392966 10774834 16781746 14986274 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
8.43 | 18186108 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.87 | 19426721 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
2.97 | 12538720 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
6.90 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
6.90 | 15345470 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
2.92 | 12168785 12639820 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.44 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.45 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.99 | 8708960 |
MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
4.87 | 19446573 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.19 | 15720958 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.97 | 12676792 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.52 | 16870215 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.01 | 10903974 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.58 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.25 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.14 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.14 | 12646999 15346721 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.21 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
31.71 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
31.71 | 16962696 16226777 16322080 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
31.71 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Chromium |
31.71 | 17934191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
31.71 | 18776723 8314463 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Mercury |
31.71 | 17934191 |
MESH:D007674 |
Kidney Diseases |
|
Potassium Dichromate |
31.71 | 19665454 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
31.71 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
11.30 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
11.30 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.30 | 12371664 |
MESH:D007896 |
Leishmaniasis |
|
Antimony |
4.62 | 12019027 15220340 21182181 10953559 21063981 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Antimony |
4.48 | 11475954 8889330 19141829 |
MESH:D007897 |
Leishmaniasis, Mucocutaneous |
|
Antimony |
5.26 | 10651420 9643325 10881086 11370249 7854095 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Antimony |
8.16 | 8142506 7854095 20495762 11105143 1899875 7554475 7875148 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Antimony Potassium Tartrate |
8.16 | 12707265 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Antimony Potassium Tartrate |
4.37 | 9834237 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.58 | 19014921 19784758 16610002 16611625 11587558 12969438 12587719 19460945 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.04 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
6.98 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
6.98 | 15890375 2125692 18177683 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
6.98 | 15276417 16712894 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.50 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
5.50 | 8603461 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.02 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.47 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.47 | 17077188 17306315 15276417 19931552 16712894 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.00 | 16487513 19082730 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.34 | 19513568 |
MESH:D008569 |
Memory Disorders |
|
Methylmercury Compounds |
4.69 | 18436314 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.56 | 16801185 |
MESH:D009069 |
Movement Disorders |
|
Methylmercury Compounds |
5.11 | 18436314 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
4.65 | 18186108 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.58 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.58 | 18551238 7678174 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.39 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.44 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.21 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.09 | 19348381 18481113 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
7.15 | 11749123 18186108 19446573 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.15 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.69 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.23 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.23 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Levonorgestrel |
4.52 | 12665316 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.37 | 17306315 15276417 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.21 | 16870215 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.47 | 11578682 |
MESH:D010409 |
Penile Diseases |
|
Antimony |
5.50 | 9643325 |
MESH:D010493 |
Pericarditis |
|
Antimony |
5.88 | 20465667 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.15 | 15687053 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
ethinyl estradiol-desogestrel combination |
5.40 | 17105841 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.03 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Methylmercury Compounds |
4.75 | 18436314 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
3.65 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.65 | 16039940 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
9.24 | 15861022 16919318 |
MESH:D011537 |
Pruritus |
|
Levonorgestrel |
9.24 | 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.15 | 16882103 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.36 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.36 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.59 | 18572023 19524636 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.71 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.62 | 12854658 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
17.25 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
ethinyl estradiol-desogestrel combination |
17.25 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
Gestodene |
17.25 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
8.91 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Gestodene |
8.91 | 15669648 |
MESH:D014352 |
Trypanosomiasis |
|
Antimony |
5.70 | 15220340 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
7.78 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
7.78 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
7.78 | 11723127 16712894 17306315 16452187 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.22 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.22 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.77 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.57 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.08 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.75 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.20 | 17056641 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
16.74 | 15869587 14671159 |
MESH:D020246 |
Venous Thrombosis |
|
ethinyl estradiol-desogestrel combination |
16.74 | 15869587 |
MESH:D020246 |
Venous Thrombosis |
|
Levonorgestrel |
16.74 | 15869587 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.21 | 17120751 |